NEW YORK (GenomeWeb News) – Interleukin Genetics said Friday that it has received notification from the New York  Stock Exchange Alternext that the firm is not in compliance with certain listing criteria.

Specifically, the firm’s stockholders' equity is less than $6 million and it has reported losses from continuing operations and net losses in its five most recent fiscal years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.